Jiang Zhong Pharmaceutical Co Ltd
SSE:600750

Watchlist Manager
Jiang Zhong Pharmaceutical Co Ltd Logo
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Watchlist
Price: 21.99 CNY 0.96%
Market Cap: 13.8B CNY
Have any thoughts about
Jiang Zhong Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Jiang Zhong Pharmaceutical Co Ltd

Current Assets 2.2B
Cash & Short-Term Investments 1.1B
Receivables 621.7m
Other Current Assets 462.5m
Non-Current Assets 3.9B
Long-Term Investments 1.8B
PP&E 1.6B
Intangibles 435.2m
Other Non-Current Assets 62.1m
Current Liabilities 1.6B
Accounts Payable 119.7m
Accrued Liabilities 175.6m
Short-Term Debt 46.8m
Other Current Liabilities 1.2B
Non-Current Liabilities 693.2m
Long-Term Debt 1.1m
Other Non-Current Liabilities 692.2m

Balance Sheet
Jiang Zhong Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
606
250
898
725
1 015
927
1 100
189
550
234
Cash
0
0
0
0
0
0
0
189
550
234
Cash Equivalents
605
250
898
725
1 015
927
1 100
0
0
0
Short-Term Investments
0
0
0
0
0
704
981
2 542
2 188
1 138
Total Receivables
1 064
930
599
1 002
1 088
1 168
915
857
836
563
Accounts Receivables
112
11
14
16
4
208
172
308
312
252
Other Receivables
952
919
585
986
1 084
961
743
549
524
311
Inventory
313
158
188
194
172
243
247
378
387
406
Other Current Assets
107
30
63
47
19
19
33
98
93
56
Total Current Assets
2 090
1 369
1 747
1 968
2 294
3 062
3 275
4 064
4 054
2 397
PP&E Net
777
746
750
844
962
1 067
1 060
1 289
1 579
1 626
PP&E Gross
777
746
750
844
962
1 067
1 060
1 289
1 579
1 626
Accumulated Depreciation
482
515
563
612
668
755
842
937
1 034
1 118
Intangible Assets
374
349
336
326
316
360
378
396
379
401
Goodwill
0
0
0
0
0
15
15
42
42
42
Note Receivable
0
0
0
0
14
0
0
0
0
0
Long-Term Investments
58
192
203
187
193
218
157
159
175
1 597
Other Long-Term Assets
28
23
29
40
39
38
40
48
47
65
Other Assets
0
0
0
0
0
15
15
42
42
42
Total Assets
3 327
N/A
2 678
-19%
3 066
+14%
3 364
+10%
3 817
+13%
4 759
+25%
4 924
+3%
5 998
+22%
6 276
+5%
6 129
-2%
Liabilities
Accounts Payable
180
45
48
88
120
56
46
163
182
118
Accrued Liabilities
71
50
70
95
137
155
115
170
260
243
Short-Term Debt
253
20
30
0
7
41
32
70
54
94
Current Portion of Long-Term Debt
0
0
60
0
0
0
0
2
2
1
Other Current Liabilities
178
207
218
147
190
496
409
912
1 179
1 130
Total Current Liabilities
683
323
426
330
454
749
602
1 317
1 678
1 586
Long-Term Debt
498
0
0
0
0
0
0
3
1
1
Deferred Income Tax
0
0
0
0
0
28
20
23
22
17
Minority Interest
56
0
0
0
0
364
374
579
604
644
Other Liabilities
13
1
24
119
110
58
51
73
68
49
Total Liabilities
1 250
N/A
324
-74%
450
+39%
449
0%
564
+26%
1 199
+113%
1 047
-13%
1 995
+91%
2 373
+19%
2 297
-3%
Equity
Common Stock
300
300
300
300
420
525
630
630
630
629
Retained Earnings
1 228
1 505
1 765
2 063
2 398
2 600
2 812
3 008
2 878
2 794
Additional Paid In Capital
549
549
551
553
435
435
435
408
427
425
Treasury Stock
0
0
0
0
0
0
0
43
32
16
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
2 077
N/A
2 354
+13%
2 616
+11%
2 915
+11%
3 253
+12%
3 561
+9%
3 877
+9%
4 003
+3%
3 904
-2%
3 832
-2%
Total Liabilities & Equity
3 327
N/A
2 678
-19%
3 066
+14%
3 364
+10%
3 817
+13%
4 759
+25%
4 924
+3%
5 998
+22%
6 276
+5%
6 129
-2%
Shares Outstanding
Common Shares Outstanding
630
630
630
630
630
630
630
624
624
626

See Also

Discover More